Innovative Biotechnology for Generation of Cardiac Tissue
Heart transplantation remains the only curative treatment for end-stage heart failure. This life-saving option continues to be limited by the low number of organ donors, graft rejection and adverse effects of immunosuppressants. Engineering bioartificial hearts from acellular native-derived scaffold...
保存先:
| 主要な著者: | , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI AG
2021-06-01
|
| シリーズ: | Applied Sciences |
| 主題: | |
| オンライン・アクセス: | https://www.mdpi.com/2076-3417/11/12/5603 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|
